MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for ext...Show More
products_or_servicesAdvanced wound solutions including EPIFIX, EPICORD, and AMNIOFIX; advanced surgical solutions like AMNIOBURN and HELIOGEN; and medical education and reimbursement services.